Infrequent mutation of TRAIL receptor 2 (TRAIL-R2/DR5) in transitional cell carcinoma of the bladder with 8p21 loss of heterozygosity

Cancer Letters

Volumn 220, Issue 2, 2005, Pages 137-144

  Adams, Jacqui ^a   Cuthbert Heavens, Darren ^a   Bass, Sylvia ^a   Knowles, Margaret A ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

8p21; Mutation; Transitional cell carcinoma; Tumour necrosis factor related apoptosis inducing ligand receptor 2

Indexed keywords

DEATH RECEPTOR 5;

ANIMAL CELL; ARTICLE; BLADDER CARCINOMA; CANCER CELL CULTURE; CHROMOSOME 8P; CONTROLLED STUDY; GENE FREQUENCY; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN TARGETING; RAT; TRANSITIONAL CELL CARCINOMA;

EID: 17644368572     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.06.052     Document Type: Article

References (70)

1. C. Choi, M.H. Kim, S.W. Juhng, and B.R. Oh Loss of heterozygosity at chromosome segments 8p22 and 8p11.2-21.1 in transitional-cell carcinoma of the urinary bladder Int. J. Cancer 86 2000 501 505
2. K. Ohgaki, A. Iida, O. Ogawa, Y. Kubota, M. Akimoto, and M. Emi Localization of tumor suppressor gene associated with distant metastasis of urinary bladder cancer to a 1-Mb interval on 8p22 Genes Chromosomes Cancer 25 1999 1 5
3. L.A. Takle, and M.A. Knowles Deletion mapping implicates two tumor suppressor genes on chromosome 8p in the development of bladder cancer Oncogene 12 1996 1083 1087
4. G.S. Bova, D. MacGrogan, A. Levy, S.S. Pin, R. Bookstein, and W.B. Isaacs Physical mapping of chromosome 8p22 markers and their homozygous deletion in a metastatic prostate cancer Genomics 35 1996 46 54
5. R. Jenkins, S. Takahashi, K. DeLacey, E. Bergstralh, and M. Lieber Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer Genes Chromosomes Cancer 21 1998 131 143
6. J. Kagan, J. Stein, R.J. Babaian, Y.S. Joe, L.L. Pisters, A.B. Glassman, A.C. von Eschenbach, and P. Troncoso Homozygous deletions at 8p22 and 8p21 in prostate cancer implicate these regions as the sites for candidate tumor suppressor genes Oncogene 11 1995 2121 2126
7. J.A. Macoska, T.M. Trybus, P.D. Benson, W.A. Sakr, D.J. Grignon, and K.D. Wojno Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer Cancer Res. 55 1995 5390 5395
8. H. Matsuyama, Y. Pan, L. Skoog, B. Tribukait, K. Naito, and P. Ekman Deletion mapping of chromosome 8p in prostate cancer by fluorescence in situ hybridization Oncogene 9 1994 3071 3076
9. M.A. Prasad, T.M. Trybus, K.J. Wojno, and J.A. Macoska Homozygous and frequent deletion of proximal 8p sequences in human prostate cancers: identification of a potential tumor suppressor gene site Genes Chromosomes Cancer 23 1998 255 262
10. H. Suzuki, M. Emi, A. Komiya, Y. Fujiwara, R. Yatani, Y. Nakamura, and J. Shimazaki Localization of a tumor suppressor gene associated with progression of human prostate cancer within a 1.2 Mb region of 8p22-p21.3 Genes Chromosomes Cancer 13 1995 168 174
11. A.K. El-Naggar, M.M. Coombes, J.G. Batsakis, W.K. Hong, H. Goepfert, and J. Kagan Localization of chromosome 8p regions involved in early tumorigenesis of oral and laryngeal squamous carcinoma Oncogene 16 1998 2983 2987
12. C.S. Ishwad, M. Shuster, U. Bockmuhl, N. Thakker, P. Shah, and C. Toomes Frequent allelic loss and homozygous deletion in chromosome band 8p23 in oral cancer Int. J. Cancer 80 1999 25 31
13. J.B. Sunwoo, M.S. Holt, D.M. Radford, C. Deeker, and S.B. Scholnick Evidence for multiple tumor suppressor genes on chromosome arm 8p in supraglottic laryngeal cancer Genes Chromosomes Cancer 16 1996 164 169
14. C.L. Wu, L. Roz, P. Sloan, A.P. Read, S. Holland, and S. Porter Deletion mapping defines three discrete areas of allelic imbalance on chromosome arm 8p in oral and oropharyngeal squamous cell carcinomas Genes Chromosomes Cancer 20 1997 347 353
15. M. Emi, Y. Fujiwara, T. Nakajima, E. Tsuchiya, H. Tsuda, and S. Hirohashi Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer Cancer Res. 52 1992 5368 5372
16. Y. Fujiwara, H. Ohata, M. Emi, K. Okui, K. Koyama, and E. Tsuchiya A 3-Mb physical map of the chromosome region 8p21.3-p22, including a 600-kb region commonly deleted in human hepatocellular carcinoma, colorectal cancer, and non-small cell lung cancer Genes Chromosomes Cancer 10 1994 7 14
17. P. Pineau, H. Nagai, S. Prigent, Y. Wei, G. Gyapay, and J. Weissenbach Identification of three distinct regions of allelic deletions on the short arm of chromosome 8 in hepatocellular carcinoma Oncogene 18 1999 3127 3134
18. R.F. Chuaqui, J. Sanz-Ortega, C. Vocke, W.M. Linehan, J. Sanz-Esponera, and Z. Zhuang Loss of heterozygosity on the short arm of chromosome 8 in male breast carcinomas Cancer Res. 55 1995 4995 4998
19. M.L. Yaremko, W.M. Recant, and C.A. Westbrook Loss of heterozygosity from the short arm of chromosome 8 is an early event in breast cancers Genes Chromosomes Cancer 13 1995 186 191
20. T. Yokota, M. Yoshimoto, F. Akiyama, G. Sakamoto, F. Kasumi, Y. Nakamura, and M. Emi Localization of a tumor suppressor gene associated with the progression of human breast carcinoma within a 1-cM interval of 8p22-p23.1 Cancer 85 1999 447 452
21. R. Baffa, R. Santoro, F. Bullrich, B. Mandes, H. Ishii, and C.M. Croce Definition and refinement of chromosome 8p regions of loss of heterozygosity in gastric cancer Clin. Cancer Res. 6 2000 1372 1377
22. H. Lassus, M.P. Laitinen, M. Anttonen, M. Heikinheimo, L.A. Aaltonen, O. Ritvos, and R. Butzow Comparison of serous and mucinous ovarian carcinomas: distinct pattern of allelic loss at distal 8p and expression of transcription factor GATA-4 Lab. Invest. 81 2001 517 526
23. K. Wright, P.J. Wilson, J. Kerr, K. Do, T. Hurst, and S.K. Khoo Frequent loss of heterozygosity and three critical regions on the short arm of chromosome 8 in ovarian adenocarcinomas Oncogene 17 1998 1185 1188
24. J. Bruch, G. Wohr, R. Hautmann, T. Mattfeldt, S. Bruderlein, and P. Moller Chromosomal changes during progression of transitional cell carcinoma of the bladder and delineation of the amplified interval on chromosome arm 8q Genes Chromosomes Cancer 23 1998 167 174
25. R.M. Hovey, L. Chu, M. Balazs, S. DeVries, D. Moore, and G. Sauter Genetic alterations in primary bladder cancers and their metastases Cancer Res. 58 1998 3555 3560
26. A. Kallioniemi, O.-P. Kallioniemi, G. Citro, G. Sauter, S. DeVries, and R. Kerschmann Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridisation Genes Chromosomes Cancer 12 1995 213 219
27. J. Richter, U. Wagner, P. Schraml, R. Maurer, G. Alund, and H. Knonagel Chromosomal imbalances are associated with a high risk of progression in early invasive (pT1) urinary bladder cancer Cancer Res. 59 1999 5687 5691
28. U. Wagner, L. Bubendorf, T.C. Gasser, H. Moch, J.P. Gorog, and J. Richter Chromosome 8p deletions are associated with invasive tumor growth in urinary bladder cancer Am. J. Pathol. 151 1997 753 759
29. Y. Utada, S. Haga, T. Kajiwara, F. Kasumi, G. Sakamoto, Y. Nakamura, and M. Emi Allelic loss at the 8p22 region as a prognostic factor in large and estrogen receptor negative breast carcinomas Cancer 88 2000 1410 1416
30. M.L. Yaremko, C. Kutza, J. Lyzak, R. Mick, W.M. Recant, and C.A. Westbrook Loss of heterozygosity from the short arm of chromosome 8 is associated with invasive behavior in breast cancer Genes Chromosomes Cancer 16 1996 189 195
31. M.C. Crundwell, S. Chughtai, M. Knowles, L. Takle, M. Luscombe, and J.P. Neoptolemos Allelic loss on chromosomes 8p, 22q and 18q (DCC) in human prostate cancer Int. J. Cancer 69 1996 295 300
32. M.J. Haggman, K.J. Wojno, C.P. Pearsall, and J.A. Macoska Allelic loss of 8p sequences in prostatic intraepithelial neoplasia and carcinoma Urology 50 1997 643 647
33. M.R. Emmert-Buck, C.D. Vocke, R.O. Pozzatti, P.H. Duray, S.B. Jennings, and C.D. Florence Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia Cancer Res. 55 1995 2959 2962
34. L.X. Qin, Z.Y. Tang, J.S. Sham, Z.C. Ma, S.L. Ye, and X.D. Zhou The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma Cancer Res. 59 1999 5662 5665
35. K.C. Halling, A.J. French, S.K. McDonnell, L.J. Burgart, D.J. Schaid, and B.J. Peterson Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers J. Natl Cancer Inst. 91 1999 1295 1303
36. A. Hirano, M. Emi, M. Tsuneizumi, Y. Utada, M. Yoshimoto, and F. Kasumi Allelic losses of loci at 3p25.1, 8p22, 13q12, 17p13.3, and 22q13 correlate with postoperative recurrence in breast cancer Clin. Cancer Res. 7 2001 876 882
37. S.B. Scholnick, B.H. Haughey, J.B. Sunwoo, S.K. el-Mofty, J.D. Baty, J.F. Piccirillo, and M.R. Zequeira Chromosome 8 allelic loss and the outcome of patients with squamous cell carcinoma of the supraglottic larynx J. Natl Cancer Inst. 88 1996 1676 1682
38. J.A. Martinez-Climent, E. Vizcarra, D. Sanchez, D. Blesa, I. Marugan, and I. Benet Loss of a novel tumor suppressor gene locus at chromosome 8p is associated with leukemic mantle cell lymphoma Blood 98 2001 3479 3482
39. P.R. Kelemen, M.L. Yaremko, A.H. Kim, A. Montag, F. Michelassi, and C.A. Westbrook Loss of heterozygosity in 8p is associated with microinvasion in colorectal carcinoma Genes Chromosomes Cancer 11 1994 195 198
40. C.B. Thompson Apoptosis in the pathogenesis and treatment of disease Science 267 1995 1456 1462
41. T. Arai, Y. Akiyama, S. Okabe, K. Saito, T. Iwai, and Y. Yuasa Genomic organization and mutation analyses of the DR5/TRAIL receptor 2 gene in colorectal carcinomas Cancer Lett. 133 1998 197 204
42. P. Golstein Cell death: TRAIL and its receptors Curr. Biol. 7 1997 R750 R753
43. A. Ashkenazi, and V.M. Dixit Death receptors: signaling and modulation Science 281 1998 1305 1308
44. K. Ichikawa, W. Liu, L. Zhao, Z. Wang, D. Liu, and T. Ohtsuka Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity Nat. Med. 7 2001 954 960
45. S.H. Lee, M.S. Shin, H.S. Kim, H.K. Lee, W.S. Park, and S.Y. Kim Alterations of the DR5/TRAIL receptor 2 gene in non-small cell lung cancers Cancer Res. 59 1999 5683 5686
46. S.I. Pai, G.S. Wu, N. Ozoren, L. Wu, J. Jen, D. Sidransky, and W.S. El-Deiry Rare loss-of-function mutation of a death receptor gene in head and neck cancer Cancer Res. 58 1998 3513 3518
47. M.S. Shin, H.S. Kim, S.H. Lee, W.S. Park, S.Y. Kim, and J.Y. Park Mutations of tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) and receptor 2 (TRAIL-R2) genes in metastatic breast cancers Cancer Res. 61 2001 4942 4946
48. S.H. Lee, M.S. Shin, H.S. Kim, H.K. Lee, W.S. Park, and S.Y. Kim Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphoma Oncogene 20 2001 399 403
49. W.S. Park, J.H. Lee, M.S. Shin, J.Y. Park, H.S. Kim, and Y.S. Kim Inactivating mutations of KILLER/DR5 gene in gastric cancers Gastroenterology 121 2001 1219 1225
50. G.S. Wu, T.F. Burns, E.R. McDonald 3rd, W. Jiang, R. Meng, and I.D. Krantz KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene Nat. Genet. 17 1997 141 143
51. W.G. Wu, J.C. Soria, L. Wang, B.L. Kemp, and L. Mao TRAIL-R2 is not correlated with p53 status and is rarely mutated in non-small cell lung cancer Anticancer Res. 20 2000 4525 4529
52. O. Monni, H. Joensuu, K. Franssila, and S. Knuutila DNA copy number changes in diffuse large B-cell lymphoma-comparative genomic hybridization study Blood 87 1996 5269 5278
53. H. Ohata, M. Emi, Y. Fujiwara, K. Higashino, K. Nakagawa, R. Futagami, E. Tsuchiya, and Y. Nakamura Deletion mapping of the short arm of chromosome 8 in non-small cell lung carcinoma Genes Chromosomes Cancer 7 1993 85 88
54. K. van der Bosch, I. Becker, L. Savelyeva, S. Bruderlein, P. Schlag, and M. Schwab Deletions in the short arm of chromosome 8 are present in up to 90% of human colorectal cancer cell lines Genes Chromosomes Cancer 5 1992 91 95
55. H.B. Grossman, G. Wedemeyer, L. Rem, G.L. Wilson, and B. Cox Improved growth of human urothelial carcinoma cell cultures J. Urol. 136 1986 953 959
56. C.C. Rigby, and L.M. Franks A human tissue culture cell line from a transitional cell tumour of the urinary bladder: growth, chromosone pattern and ultrastructure Br. J. Cancer 24 1970 746 754
57. A.A. Kyriazis, A.P. Kyriazis, W.B. McCombs III, and W.B.J. Peterson Morphologiccal, biological and biochemical characteristics of human bladder transitional cel carcinomas grown in tissue culture Cancer Res. 44 1984 3997 4005
58. S. Paulie, Y. Hansson, M.L. Lundblad, and P. Perimann Lectins as probes for identification of tumor-associated antigens on urothelial and colonic carcinoma cell lines Int. J. Cancer 31 1983 297 303
59. R.D. Williams Human urologic cancer cell lines Invest. Urol. 17 1980 359 363
60. A.Y. Elliot, P. Cleveland, J. Cervenka, A.E. Castro, N. Stein, T.R. Hakala, and E.E. Fraley Characterization of a cell line from human transitional cell cancer of the urinary tract J. Natl Cancer Inst. 53 1974 1341 1349
61. J. Bubenik, M. Baresova, V. Viklicky, J. Jakoubkova, H. Sainerova, and J. Donner Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen Int. J. Cancer 11 1973 765 773
62. S. Rasheed, M.B. Gardner, R.W. Rongey, W.A. Nelson-Rees, and P. Arnstein Human bladder carcinoma: characterization of two new tumor cell lines and search for tumor viruses J. Natl Cancer Inst. 58 1977 881 890
63. S.V. Williams, K.D. Sibley, A.M. Davies, H. Nishiyama, N. Hornigold, and J. Coulter Molecular genetic analysis of chromosome 9 candidate tumor-suppressor loci in bladder cancer cell lines Genes Chromosomes Cancer 34 2002 86 96
64. C. O'Toole, Z.H. Price, Y. Ohnuki, and B. Unsgaard Ultrastructure, karyology and immunology of a cell line originated from a human transitional-cell carcinoma Br. J. Cancer 38 1978 64 76
65. C. O'Toole, S. Nayak, Z. Price, W.H. Gilbert, and J. Waisman A cell line (SCaBER) derived from squamous cell carcinoma of the human urinary bladder Int. J. Cancer 17 1976 707 714
66. M.A. Knowles, M.E. Shaw, and A.J. Proctor Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms Oncogene 8 1993 1357 1364
67. A.J. Keen, and M.A. Knowles Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder Oncogene 9 1994 2083 2088
68. G.R. Screaton, J. Mongkolsapaya, X.N. Xu, A.E. Cowper, A.J. McMichael, and J.I. Bell TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL Curr. Biol. 7 1997 693 696
69. M.P. Lee, S. Brandenburg, G.M. Landes, M. Adams, G. Miller, and A.P. Feinberg Two novel genes in the center of the 11p15 imprinted domain escape genomic imprinting Hum. Mol. Genet. 8 1999 683 690
70. M.G. Lee, H.Y. Kim, D.S. Byun, S.J. Lee, C.H. Lee, and J.I. Kim Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma Cancer Res. 61 2001 6688 6692